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Abstract: A simple, rapid isocratic liquid chromatographic procedure with ultraviolet and fluorimetric detection is described for the 
separation and quantification of L-tryptophan (Trp) and six of its kynurenine metabolites (kynurenine, 3-hydroxykynurenine, and 
  3-hydroxyanthranilic, kynurenic, xanthurenic and anthranilic acids). Using the Perkin Elmer LC 200 system, a reverse phase Synergi 
4 µ fusion-RP80 A column (250 × 4.6 mm) (Phenomenex), and a mobile phase of 10 mM sodium dihydrogen phosphate: methanol 
(73:27, by vol) at pH 2.8 and a flow rate of 1.0–1.2 ml/min at 37 °C, a run took ∼13 min. The run took ,7 min at 40 °C and a 1.4 ml/min 
flow rate. Limits of detection of all 7 analytes were 5–72 nM and their recoveries from human plasma and rat serum and liver varied 
between 62% and 111%. This simple method is suitable for high throughput work and can be further developed to include quinolinic 
acid and other Trp metabolites.
Keywords: anthranilic acid, high-performance liquid chromatography, 3-hydroxyanthranilic acid, 3-hydroxykynurenine, kynurenic 
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Introduction
The amino acid L-tryptophan (Trp) is of   particular 
scientific and medical interest, because it is not only 
essential for protein synthesis and hence growth, but 
also the precursor of a large number of   biologically 
active metabolites, including the   cerebral   indolylamine 
serotonin, (5-hydroxytryptamine), the pineal   hormone 
melatonin and the many other metabolites of the hepatic 
kynurenine    pathway.  These  include  the  important 
redox cofactors NAD+(P+)H, the B-  vitamin-like sub-
stance nicotinic acid, the   convulsant kynurenine, the 
N-methyl-D-aspartate  (NMDA)  receptor  antagonist 
kynurenic acid and agonist quinolinic acid and the 
malaria  mosquito  gametocyte-  activating  agent  xan-
thurenic acid.   Analysis of Trp and its metabolites is 
therefore an important laboratory aid to research across 
a  wide  range  of  scientific    disciplines  and  medical 
  specialties. Many procedures exist for   separation and 
quantification of groups of the above and other metab-
olites and derivatives, using gas   chromatography-mass 
spectrometry  (GC-MS)  or  high-  performance    liquid 
chromatography  (HPLC)  with  various  detection 
  systems (for review and   references, see Molnar-Perl1). 
The HPLC technique has received greater popularity 
in analysis of Trp and its metabolites, largely because 
of  availability  of  sensitive  detection  systems  and 
the native fluorescence of some of these metabolites 
which minimised the requirement for the derivatisa-
tion needed in GC analysis.
The  presence  of  a  relatively  large  number  of 
  kynurenine  metabolites  in  mammalian    biological 
  samples  presents  a  challenge  to  analysts  when 
  developing  a  rapid  procedure  suitable  for  analysis 
of large numbers of samples. For example, current 
HPLC methods can determine between 1 and 4 Trp 
  metabolites in serum or urine in 15–70 min2–7 and, 
although  faster  methods  have  been  developed  for 
analysis of up to 6–9 kynurenine metabolites, a run 
still  takes  17–40  min  and  most  require  additional 
  pre-column  sample  deproteinisation  and  clean-up, 
and  the  use  of  gradient  elution.8–11  More  recently, 
HPLC-MS has been used for more rapid separation 
of  kynurenines  in  two  studies.  In  one,12  only Trp, 
  kynurenine and 3-hydroxykynurenine were separated 
within  8  min  using  on-line  solid-phase  extraction, 
whereas in the other,13 Trp, 6 kynurenines, B-  vitamin 
markers  and  others  (in  total  16  analytes)  were 
  separated within 5 min. However, the use of MS was 
essential for proper identification of this large number 
of closely eluted peaks. In another earlier, but simple, 
isocratic HPLC procedure14 designed for measuring 
only Trp using UV detection, the authors reported also 
very close retention times for 8 kynurenine metabo-
lites, 4 indole metabolites and 4 other compounds. 
In this earlier study,14 Trp was sufficiently separable 
from the nearest metabolites to enable the authors to 
quantify it. In the present work, we have developed 
this procedure14 further for successful separation and 
quantification of Trp and at least 6 of its kynurenine 
metabolites  within  7  min  and  suggest  that  further 
developmental work may widen this simple proce-
dure to include other Trp metabolites.
Materials and Methods
chemicals and other materials
Tryptophan  (Trp),  kynurenine  (K),  3-hydroxykynurenine 
(3-HK), 3-hydroxyanthranilic acid (3-HAA), kynurenic 
acid  (KA),  xanthurenic  acid  (XA),  quinolinic  acid 
(QA), indol-3-ylacetic  acid (IAA), indol-3-  yllactic 
acid  (ILA)  and  indol-3-ylpyruvic  acid  (IPA)  were 
purchased from The Sigma-Aldrich Co. Ltd. (Fancy 
Road,  Poole,  Dorset  BH12  4QH,  UK)  and  were 
stored  as  directed  by  the  manufacturer. Water  and 
methanol (HPLC grade) were purchased from either 
V W R International (Hunter Boulevard, Magna Park, 
Leicestershire LE17 4XN, UK) or Fisher Scientific 
UK (Bishop Meadow Road,   Loughborough, Leices-
tershire LE11 5RG, UK). Acids and alkalis were pur-
chased from VWR International, were of the purest 
commercially available grades and were made up in 
HPLC-grade water. Filtration, Eppendorf and other 
tubes were purchased from Fisher or other standard 
suppliers.
Standard and other solutions
Individual solutions or mixtures containing Trp and 
its various metabolites (1 µg/ml each) were prepared 
in HPLC-grade water without or with the use of a small 
volume (1 ml) of M-NaOH (in the cases of 3-HAA, 
KA, QA and XA). AA was first dissolved in 1 ml of 
pure ethanol before dilution with water. All individ-
ual analytes and their mixtures were   initially prepared 
as neutral solutions, but, as perchloric acid extracts 
of  biological  samples  were  to  be  used  throughout, hPLc of Tryptophan and its kynurenine metabolites
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HClO4 was subsequently added to these aqueous stan-
dard solutions at a similar final concentration (6%, 
w/v) as that in the biological   sample extracts. One ml 
  portions were stored at −24 °C and used as calibrants 
within 2 months. Dilutions of the above standard mix-
ture were made for limits of detection experiments. 
The  mobile  phase  was  initially  that  described  by 
Gjerde et al,14 namely methanol: 10 mM sodium dihy-
drogen phosphate (30:70, by vol), but this ratio was 
subsequently altered to improve analyte separation. 
The 10 mM sodium phosphate buffer was prepared 
in HPLC-grade water and filtered through a cintered-
glass funnel before mixing with methanol. The free 
buffer was stored at 4 °C for up to 1 week, whereas 
the buffer-methanol mobile phase was kept at room 
temperature in its reservoir and used within 2 weeks.
Preparation of plasma,  
serum and liver extracts
To a 0.5 ml portion of human plasma or rat serum, 
0.4 ml of HPLC-grade water and 0.1 ml of 60% (w/v) 
HClO4 were added in ice-cooled tubes. The contents 
of the tubes were vortexed for 5–10 s and allowed 
to stand for 5 min before centrifugation at 14,000 g 
for  10  min  at  4  °C,  using  a  Hermle  refrigerated 
high-speed centrifuge (Hermle labortechnik GmbH, 
  Siemensstrasse 25, 78564 Wehingen, Germany). The 
supernatant was decanted and adjusted to 1 ml with 
6% (w/v) HClO4 to correct for minor volume changes 
due to plasma protein precipitation. A 0.5 ml portion 
was immediately filtered through a Vectaspin   filtration 
tube by centrifugation at 14,000 g for 10 min at 4 °C 
and the filtrate was either transferred to an HPLC 
injection  vial  for  immediate  use  or  stored  (along 
with the unfiltered portion) at −24 °C for subsequent 
  analysis. For rat liver extracts, to a 1 g piece of previ-
ously frozen liver, 1 ml of ice-cold HPLC water and 
2 ml of ice-cold 12% (w/v) HClO4 were added and the 
mixture was homogenised for ∼1 min using an Ultra-
Turrax homogeniser. The homogenates were allowed 
to stand in ice-cold tubes for 10 min before centrifu-
gation at 6,000 g for 10 min at 4 °C. The supernatants 
were decanted and adjusted to 4 ml with 6% (w/v) 
HClO4 to correct for small volume decreases due to 
tissue precipitation. A 0.5 ml portion of each homo-
genate was filtered and used or stored as described 
above for plasma and serum extracts.
Recovery of Trp and kynurenine 
metabolites from human plasma  
and rat liver and serum
A concentrated mixture of Trp and its 6 kynurenine 
metabolites was prepared in 6% (w/v) HClO4 and small 
volumes were added to different human plasmas, rat 
sera and rat livers (n = 4 each) shortly before preparing 
extracts in 6% (w/v) HClO4, as described above, such 
that final concentrations of Trp and its 6 kynurenine 
metabolites were 2, 1 and 0.5 µg/ml. Untreated HClO4 
extracts of these biological samples acted as controls. 
Standards containing these different concentrations 
were  run  as  calibrants. All  standards  and  extracts 
were chromatographed under the   standard conditions 
described below.
Stability of kynurenines after frozen 
storage of perchloric acid tissue extracts
Stability was tested using perchloric acid extracts of 
normal human plasma samples prepared as described 
above. Freshly prepared extracts were analysed on 
the same day under the standard conditions described 
below. Portions of these extracts were then frozen 
at −24 °C for periods of 3 days and 1–4 weeks, after 
which they were reanalysed. Plasmas were isolated 
from blood samples taken before and hourly for up 
to 7 h during the acute Trp loading test in an earlier 
study.15 As the concentrations of Trp and its kynure-
nine metabolites varied widely during this test, we 
were able to assess stability at different metabolite 
concentrations. For each of the above storage time 
points, plasma extracts from two different subjects 
were used. Stability was expressed as a percentage 
of  the  mean  values  observed  in  freshly  analysed 
extracts.
Limits of detection and linearity
A  solution  containing  2  µg/ml  each  of  Trp  and 
its  6  kynurenine  metabolites  was  prepared  in  6% 
(w/v) HClO4, from which serial dilutions were made 
down to 0.001 µg/ml. The original and its various 
dilutions were chromatographed under the standard 
conditions  described  below.  Linearity  was  plot-
ted and limit of detection (LOD) noted using both 
UV and, where appropriate, fluorescence detection. 
LOD using UV was performed at 220 nm, whereas 
that for fluorescing metabolites was first examined Badawy and Morgan
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at  the  common  254/404  nm  (excitation/emission) 
  wavelength   combination, but was followed by using 
the specific wavelength maxima of each compound. 
For  all  other  experiments,  220  nm  (UV)  and  the 
254/404 nm combination (fluorescence) were adopted. 
The signal to noise (S/N) ratio in the LOD and all 
other experiments was 5:1 or higher (see below).
Between-day variations
A  mixture  of  7  components  (1  µg/ml  each)  was 
  chromatographed  under  the  standard    conditions 
described below on 16 different days over a 4-week 
period  to  determine  between-day  variations. 
  Within-day variations were not examined, as running 
the standard mixture more than once daily was very 
infrequent. When this occurred, variations between 
duplicate standards were negligible (∼,1%).
equipment and data handling
A  Perkin-Elmer  LC  200  quaternary  pump  with  a 
  column oven, a degasser, a liquid autosampler and a 
UV/VIS and a fluorescence (LS 30) detector in series 
were used. The system was run isocratically using 
a Synergi 4 µ reverse-phase Fusion-RP80A column 
(250 × 4.6 mm) with guard column   (Phenomenex). 
Operation of the system, data processing and han-
dling  were  all  performed  by  the  associated  Total 
Chrome  software.  A  standard  mixture  containing 
1 µg/ml of each component was used as calibrant at 
the start of each run. UV detection was performed 
at 220 nm throughout, as lower levels of K and its 
metabolites could not be detected at higher wave-
lengths. Fluorimetric detection was performed using 
the Perkin-Elmer LS 30 spectrophotofluorimeter and 
a suitable flow cell. The LS 30 has facilities for alter-
ing the excitation/emission wavelengths through the 
timed events function, thus enabling multiple wave-
length detection to be operated during a run and this 
was performed in LOD experiments for detection of 
Trp and its 3 fluorescing metabolite (3-HAA, KA and 
AA) at their specific excitation/emission maxima (see 
the Results section). The total Chrome software used 
was a   versatile and powerful system that was capable 
of detecting and quantifying very tiny peaks as will 
be seen from the results in Table 5 and   Figure 4. The 
default setting for the signal/noise (S/N) ratio of this 
software was 5:1. When a peak was not quantified 
by the software because of the absence of a baseline, 
a click on the S/N ratio button prompted the soft-
ware to suggest a new ratio (usually 5 or higher) to 
enable  area  measurement. A  further  facility  of  the 
software is   manual integration, which, though not as 
accurate as the automatic software equivalent, can on 
occasion elicit a very tiny peak if the baseline is drawn 
accurately at the relevant retention time. A S/N ratio of 
5 was used in almost all experiments, though a higher 
setting (50:1 or 100:1) was occasionally applied in 
a few fluorimetric detections. Although the fluores-
cence of KA is known16 to be enhanced by addition of 
Zn2+, this cation was not added to the mobile phase to 
avoid formation of its insoluble phosphate salt.
Standard and other conditions
After  confirming  the  previous  observation14  of  the 
poor separation of kynurenine metabolites when the 
methanol concentration in the mobile phase was 30%, 
various attempts were made to improve the   separation, 
first  by  changing  the  methanol    concentration, 
then  the  pH,  the  flow  rate  and  finally  the    column 
oven    temperature.  Some  of  these  attempts  will  be 
described in the Results section below, but, for Trp 
and 6 of its kynurenine metabolites, we adopted the 
  following standard conditions: a mobile phase of 27% 
  methanol: 73% 10 mM sodium dihydrogen phosphate 
(final pH 2.8) was used at a flow rate of 1.4 ml/min at 
40 °C with UV (220 nm) and fluorescence detection 
(254/404 nm) in series. All standards and biological 
sample extracts were in 6% (w/v) HClO4 and 10 µL 
samples were auto-injected at 4 °C. Retention times 
of analytes in mixture were determined from those of 
individual components and, additionally for QA and 
3-HK, by spiking biological sample extracts with a 
range of concentrations of each substance.
Results
Separation of Trp and its metabolites
Initial attempts and changing the methanol 
content of the mobile phase
Initially, we hoped to separate most of the   components 
tested in the original procedure14 and so used Trp, 7 
kynurenines (QA, 3-HK, K, 3-HAA, XA, KA and 
AA)  and  3  indole  metabolites  of  the  tryptamine 
and transamination pathways, namely IAA, ILA and 
IPA. We first tested the mobile phase in its original 
composition,14  namely  30/70  methanol/phosphate 
buffer at a 1 ml/min flow rate, but at 37 °C, rather hPLc of Tryptophan and its kynurenine metabolites
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than room temperature. Some of these metabolites 
  co-eluted  and  one  or  two  were  not  eluted  within 
20 min. Based on the principle of solvent strength 
selectivity,  the  decreased  retention  of  co-eluting 
substances observed here is due to the mobile phase 
being less polar (ie,   having a higher methanol   content 
than  would  be    desirable).  Consequently,  it  was 
immediately clear that the methanol content should 
be  decreased. A  range  of  methanol  concentrations 
was tested between 15% and 40% (at 1 ml/min and 
37 °C). The best separation was achieved with a 27% 
methanol concentration, which was adopted in most 
subsequent studies. Various attempts to improve the 
separations were made by changing the pH, tempera-
ture and flow rate. At a 0.9 ml/min flow rate at 37 °C 
and using neutralised solutions of analytes for injec-
tion, we found that pH 5.6 achieved the best separa-
tion of 10 of the above 11 components, within 16 min, 
with QA escaping in the solvent front. IPA detection 
was, however, variable, almost certainly due to its 
keto-enol  tautomerisation. As  our  primary  interest 
was concerned with analysis of kynurenine metabo-
lites in biological samples, all subsequent attempts 
were made using Trp and the above 7 kynurenines.
Separation of Trp and kynurenines
This  was  attempted  by  changing  the  pH,  column 
oven temperature and flow rate. At pH 2.8, a flow rate 
of 1.0–1.2 ml/min and at 37 °C, 6 kynurenines plus 
Trp were separated within ∼13 min. Figure 1 shows 
a  typical  such  separation  with  both  UV  (220  nm) 
and fluorimetric (254/404 nm) detection. As the UV 
detector was used first, a difference in retention time 
of  Trp  and  its  3  fluorescing  metabolites  3-HAA, 
KA and AA of ∼ 0.2 min can be seen by comparing 
Figure 1(a) with (b).
Increasing the temperature to 40 °C and the flow 
rate  to  1.4  ml/min  resulted  in  a  faster  separation, 
within 7 min without altering the pattern of elution, 
as shown in Figure 2. QA was not detectable, having 
presumably been eluted in the solvent front. These 
latter (standard) conditions were used for all subse-
quent experiments for method validation (see also the 
Materials and Methods section).
Separation of quinolinic acid
This was achieved by lowering the pH to 2.0, the 
flow rate to 1.15 ml/min, the methanol content of 
the mobile phase to 25% (v/v), and the column oven 
temperature to 37 °C. Under these conditions, QA 
appeared immediately before 3-HK and the pattern 
of elution of kynurenines was altered, as shown in 
Figure 3. QA separation was, however variable and 
further improvements will be necessary to achieve a 
more reproducible elution of this metabolite.
Linearity and limits of detection
Limits  of  detection  (LOD)  are  shown  in  Table  1. 
The UV LOD of the 7 compounds 3-HK, K, Trp, 
3-HAA,  XA,  KA  and AA  varied  between  22  and 
72 nM. Using fluorimetric detection at 254/404 nm 
for the fluorescing compounds Trp, 3-HAA, KA and 
AA gave LOD not different from those using UV. 
However, when LOD of these 4 compounds were 
determined  at  their  respective  optimum  excitation 
and emission wavelengths, values of 5, 32, 26 and 
7 nM respectively were obtained, thus demonstrating 
the 2–10-fold superiority of fluorimetric detection. 
These levels of LOD correspond to concentrations of 
the 7   compounds of between 1 and 10 ng/ml. Linearity 
was observed for all concentration ranges between 
those  at  the  LOD  and  the  highest  concentrations 
tested (1 or 2 µg/ml).
Between-day variations in analyte 
determination
Analysis of Trp and its 6 kynurenine metabolites was 
performed  in  a  freshly  prepared  standard  mixture 
  containing 1 µg/ml of each component and repeatedly 
for 16 days over a 4-week period on   frozen portions of 
this mixture. The data in Table 2 give the coefficients 
of  variation  (CV),  as  a  %,  between  days  for  16 
determinations and show the CV’s to vary between 
1.9% and 7.7%.
Recovery from human plasma  
and rat liver and serum
As  shown  in  Table  3,  recoveries  of  Trp  and  its 
6 kynurenine metabolites from human plasma and 
rat serum and liver varied between 62% and 111%. 
As there were only modest differences in recoveries 
of  metabolites  when  added  at  2,  1  or  0.5  µg/ml, 
compared  with  differences  in  recoveries  between 
the quadruplicate human or rat samples, the recov-
ery values for all three analyte concentrations were 
averaged for each of the four individual biological Badawy and Morgan
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samples and presented in Table 2 as the means for 
each    parameter. As  shown,  recoveries  of  Trp  and 
its  6  kynurenine  metabolites  from  human  plasma, 
rat  serum  and  rat  liver  varied  between  76%–95%, 
62%–103% and 75%–111% respectively.
Stability of perchloric acid extracts  
of human plasma samples upon  
frozen storage
Stability was examined in 6% (w/v) HClO4 extracts 
of human plasma samples stored at −24 °C for up to 
4 weeks. As the results in Table 4 show,   stability of 
Trp and 5 of its kynurenine metabolites was main-
tained  for  up  to  4  weeks  of  frozen  storage.  Only 
3-HAA  showed  a  small  loss  of  7%–8%  after  3–4 
weeks. Stability was not influenced by the presence 
of larger amounts of Trp or its metabolites in samples 
derived from subjects receiving acute Trp loads.
normal values in human plasma
The  results  in  Table  5  show  the  normal  fast-
ing values for Trp and 6 kynurenine metabolites 
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Figure 1. HPLC chromatograms of tryptophan and six kynurenines with ultraviolet (UV) and fluorimetric detection.
notes: A mixture containing 1 µg/ml each of tryptophan (Trp) and 6 kynurenines [kynurenine (K), 3-hydroxykynurenine (3-hK), 3-hydroxyanthranilic acid 
(3-hAA), kynurenic acid (KA), xanthurenic acid (XA) and anthranilic acid (AA)] was chromatographed isocratically using a mobile phase of methanol: 
10 mM sodium dihydrogen phosphate (27:73 by vol) at a final pH of 2.8, a flow rate of 1.15/min, and a column oven temperature of 37 °c. Other details are 
as described in the Materials and Methods section. Peaks were UV detected at 220 nm (a) or fluorimetrically at an excitation/emission wavelength combi-
nation of 254/404 nm (b). Note that UV preceded fluorimetric detection, hence the ∼0.2 min lag in peak retention time in (b) for fluorescing compounds.hPLc of Tryptophan and its kynurenine metabolites
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for  114  healthy  US  subjects  of  diverse  ethnicity 
corrected for full recovery. These data will be dis-
cussed below.
The chromatograms in Figure 4 depict the profile 
of a fasting plasma sample from a healthy US subject. 
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and a column oven temperature of 40 °c. Other details are as described in the Materials and Methods section. Peaks were detected at 220 nm (UV 
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Trp and all 6 kynurenines were quantified using UV 
and fluorimetric detection. Concentrations (in µM) of 
3-HK, K, Trp, 3-HAA, XA, KA and AA were 1.75, 
3.28, 47, 1.44, 0.75, 0.0117 and 0.0027 respectively. 
The ability of the Total Chrome software to detect and Badawy and Morgan
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quantify tiny UV peaks is clearly seen in Figure 4a. 
With  fluorimetric  detection  at  254/404  (Fig.  4b), 
only AA  among  fluorescing  compounds  could  not 
be quantified at the above sub-optimal wavelength 
combination.
Discussion
Analysis of tryptophan and its kynurenine metabo-
lites presents a challenge to researchers across many 
scientific disciplines and medical specialties. Most 
current analytical procedures involve relatively long 
runs of between 15 and 70 min for Trp and a small 
number  of  metabolites  (up  to  4),2–7  or  17–40  min 
for a larger number (6–9).8–11 In more recent stud-
ies using LC-MS, faster separations were achieved. 
Thus, using solid-phase extraction, Trp and 2 kynure-
nines were separated in 8 min,12 whereas in another 
study,13 Trp, 6 kynurenines and 9 other compounds 
were separated in 5 min. In this latter study, MS was 
essential  to  identify  and  quantify  16  very  closely 
eluted substances. Thus, no method exists for sim-
ple and rapid separation of Trp and its kynurenine 
metabolites  in  a  large  number  of  samples  without 
the need for a relatively expensive MS or compli-
cated procedure. The method reported in the pres-
ent study fulfils these requirements, as Trp and 6 of 
its  kynurenine  metabolites  have  been  successfully 
separated and quantified within 7 min using a simple 
isocratic procedure (Fig. 2). Our procedure is based 
on an earlier method14 developed for quantification 
of Trp, in which 10 Trp metabolites were too closely 
eluted to achieve their satisfactory separation from 
one another. By lowering the methanol content of the 
mobile phase from the 30% (v/v) level in the original 
method14 to 27%, successful separation was achieved 
in the present study for Trp and 6 kynurenines (K, 
3-HK, 3-HAA, KA, XA and AA). The run time was 
as short as ,7 min at a column oven temperature of 
40 °C, a flow rate of 1.4 ml/min and a final pH of 
the mobile phase of 2.8. As the UV chromatogram in 
Figure 1 (a) shows, all 7 components were resolved, 
including KA and XA, the resolution of which is not 
always possible isocratically.17,18
Decreasing the pH to 2.0, the methanol content to 
25% (v/v), the flow rate to 1.15 ml/min and the col-
umn oven temperature to 37 °C resulted in detection 
of quinolinic acid (Fig. 3), but a longer run (.12 min). 
However, QA detection was variable in subsequent 
experiments. At  higher  pH,  we  were  able  initially 
to separate Trp, 6 kynurenines, excluding QA, and 
Table 2. Between-day coefficients of variation for trypto-
phan and kynurenine metabolites.
Analyte cV (%)
3-hK 7.7
K 4.3
Trp 4.1
3-hAA 4.4
KA 2.2
XA 3.5
AA 1.9
notes: cV = SD/mean. Sixteen portions of a frozen (−24 °c) standard 
mixture containing 1 µg/ml of each of the above 7 analytes were analysed 
daily over a 4-week period under the standard conditions in the Materials 
and Methods section. Abbreviations are as in Table 1.
Table 1. Limits of detection (LOD) of tryptophan and six 
kynurenines.
Analyte UV-LOD (nM) FL-LOD (nM)
3-hK 22 –
K 24 –
Trp 24 5
3-hAA 65 32
XA 49 –
KA 53 26
AA 72 7
notes: Limits of detection (LOD) were determined for 3-hydroxykynurenine 
(3-hK),  kynurenine  (K),  tryptophan  (Trp),  3-hydroxyanthranilic  acid 
(3-hAA), xanthurenic acid (XA), kynurenic acid (KA) and anthranilic acid 
(AA) using both UV and fluorescence (FL) detection. UV detection was 
performed at 220 nm, whereas fluorescence (FL) detection was at the 
excitation/emission wavelength optima of 285/390 nm (Trp), 340/420 nm 
(3-hAA), 344/390 nm (KA), 313/420 nm (AA). The standard conditions 
used and other details are given in the Materials and Methods section.
Table 3. Recovery of tryptophan and kynurenine metabo-
lites from biological material.
Metabolite Human  
plasma
Rat serum Rat liver
3-hK 83.5 ± 9.5 88.2 ± 2.7 95.4 ± 10.8
K 76.8 ± 5.9 87.4 ± 4.0 91.6 ± 2.3
Trp 95.0 ± 3.6 99.0 ± 7.1 96.8 ± 5.93
hAA 91.5 ± 5.7 62.3 ± 2.6 74.9 ± 2.1
XA 76.5 ± 9.7 103.3 ± 8.8 111.1 ± 7.6
KA 82.8 ± 3.9 88.7 ± 6.6 105.7 ± 7.3
AA 80.4 ± 7.7 99.9 ± 11.9 88.2 ± 4.2
notes: Values are means ± SeM for each group of 4 samples, each of 
which represents the average of 3 different concentrations of metabolites 
(2,  1  and  0.5  µg/ml).  Analyses  were  performed  under  the  standard 
conditions in the Materials and Methods section. For abbreviations, see 
Table 1.hPLc of Tryptophan and its kynurenine metabolites
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3 indoles (IAA, ILA and IPA) at pH 5.6 when the 
10-component mixture was injected at neutral pH. 
These  preliminary  observations  strongly  suggest 
that it is possible to develop this method further to 
include QA (currently best determined by GC-MS19), 
other kynurenine pathway metabolites (eg, picolinic, 
nicotinic and quinaldic acids) and indole metabolites, 
although a longer run time may be necessary. Such 
separation has already been achieved using gradient 
elution over 18–50 min9,10 and it therefore remains 
to be seen if this can be achieved isocratically in a 
shorter run.
Our  rapid  isocratic  procedure  was  subjected  to 
a number of validation criteria. Thus, the limits of 
  detection of Trp and 6 of its kynurenine metabolites 
varied between 1 and 10 ng/ml (5–72 nM) (Table 1). 
This  was  superior  to  some  (500–1000  nM3  and 
450–730 nM11), but similar to, or smaller than, other 
(1–30  nM12  and  7–400nM13)  previously  reported 
  findings. As can be seen from the ranges in Table 5, 
our versatile Total Chrome software was capable of 
detecting much smaller concentrations using its own 
integration   facility. Linearity was observed between 
concentrations of pure compounds at the above   limits 
of  detection  and  the  highest  tested  (7.3–13.1  µM; 
1–2 µg/ml). Higher concentrations were not tested, 
as this would have affected the peak characteristics. 
Coefficients  of  variation  between  days  (Table  2) 
varied between 1.9%–7.7%, in agreement with values 
in the literature (3.3%,7 0.9%–2.4%,9 3.1%,11 ,9%,12 
4.9%–16.9%13). Recoveries from human plasma, rat 
serum and rat liver were 76.5%–90%, 62.3%–103.3% 
and  74.9%–111.1%  respectively  (Table  3).  Our 
human  plasma  recovery  values  are  in  agreement 
with  those  previously  reported  for  human  plasma 
(98%–101%,8  75%–123%13),  serum  (91%–98%7) 
or urine (64%–100%11). Analytes in perchloric acid 
extracts of human plasma were stable following fro-
zen storage at −24 °C (Table 4) for at least 4 weeks.
The non-fluorescing compounds K, 3-HK and XA 
were detected and quantified only by UV. Because 
Trp  exists  in  biological  material  at  relatively  high 
  concentrations, it was also detectable by UV,   without 
the  need  for  fluorimetric  detection. The  latter  was 
used  for  quantification  of  3-HAA,  KA  and AA  if 
their   levels were not sufficiently detectable by UV. 
Although  elution  of  3-HAA  followed  closely  that 
of Trp, our method showed that the relatively small 
Table 4. effects of frozen storage of perchloric acid extracts of human plasma on stability of kynurenine metabolites.
Percentage of values in fresh extracts
Duration …. 
analyte
3 days 1 week 2 weeks 3 weeks 4 weeks
3-hK 100.9 ± 1.2 100.6 ± 2.3 99.0 ± 8.8 100.1 ± 1.9 99.3 ± 1.9
K 102.6 ± 3.8 95.0 ± 5.6* 103.6 ± 3.4 105.7 ± 2.2 95.7 ± 5.2
Trp 99.4 ± 0.8 101.0 ± 0.7 104.1 ± 0.7 100.3 ± 0.4 99.4 ± 4.33
3-hAA 90.0 ± 13.0* 99.6 ± 0.6 101.1 ± 3.8 92.6 ± 8.5* 92.0 ± 9.6*
KA 102.2 ± 3.8 98.5 ± 8.4* 101.5 ± 4.1 106.5 ± 2.3 103.4 ± 2.5
XA 101.7 ±1.5 94.2 ± 7.2* 98.5 ± 6.3 104.4 ± 15.2* 106.4 ± 27.8*
AA nD 95.7 ± 8.6* 103.8 ± 4.9* 104.5 ± 4.8 106.0 ± 6.2 
notes: Plasmas from blood samples taken hourly over a 7 h period from 10 normal subjects undergoing the acute tryptophan loading test in a previous 
study15 were used. Perchloric acid extracts of plasma were prepared as described in the Materials and Methods section and were analysed immediately. 
Portions of these extracts were reanalysed following storage at −24 °c for the various durations listed above. All analyses were performed under the 
standard conditions in the Materials and Methods section. Tests for each of the above durations were conducted on samples from 2 different subjects. 
Values are means ± SeM for each determination of 12 samples, except those marked with an*, which were means of 6–10 samples, due to loss of sample 
or undetectable levels in the fresh extracts. nD denotes not determined. For other abbreviations, see Table 1.
Table 5. normal fasting human plasma tryptophan and six 
kynurenine values.
parameter Mean ± seM 
(μM)
Range 
(μM)
Trp 63.3 ± 1.9 27–127
3hK 9.20 ± 0.36 1.7–17.13
K 2.15 ± 0.12 0.61–6.96
3hAA 0.28 ± 0.03 0.001–0.971
XA 0.16 ± 0.03 0.001–0.962
KA 0.12 ± 0.02 0.0003–0.9280
AA 0.069 ± 0.014 0.0005–0.8790
notes: Values are means ± SeM with ranges for n = 114. Perchloric 
acid extracts were analysed under the following conditions: a methanol: 
sodium dihydrogen phosphate (27:73, by vol) mobile phase at ph 2.8 
and a flow rate of 1.2 ml/min at 37 °c. For abbreviations, see Table 1. The 
data in this Table are based on the results of a previous study.15Badawy and Morgan
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3-HAA,  was  not covered by the much larger Trp, 
peak and that both compounds were clearly quantifi-
able separately (Fig. 4).
The normal values and ranges for Trp and 6 kynure-
nines  in  fasting  human  plasma  shown  in  Table  5 
  represent an update of the provisional   values reported 
previously15  at  an  earlier  stage  of  development  of 
this method. Normal values in rat liver and serum 
will be reported elsewhere in studies of the effects 
of   kynurenine metabolite administration on alcohol 
Figure 4. Chromatograms of a fasting human plasma sample with UV and fluorimetric detection.
notes: The fasting plasma sample profiles shown are from a previous study,15 the analyses of which were conducted at an earlier stage of development 
of this method. Conditions are as in Figure 1, except that the flow rate was 1.2 ml/min. The original graph format drawn by the software is given here 
to   emphasize the small peaks. For abbreviations, see Figure 1. note that, in this sample, KA was not detectable by UV (a), and AA was not detectable 
  fluorimetrically (b).hPLc of Tryptophan and its kynurenine metabolites
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consumption  and  metabolism.  The  mean  human 
plasma values in Table 5 of the present work have 
been  compared  with  those  in  the  literature,  which 
have been the subject of a recent review.20 Our Trp and 
K values agree with previous reports in many publi-
cations (for references, see20). Our mean values for 
3-HAA, XA, KA and AA are somewhat higher than 
those in several previous reports. However, this may 
be due to our relatively larger sample size, compared 
to those in previous studies. Thus, simple observations 
of data from our 114 subjects showed that as many as 
20–36 individual subject values matched previously 
reported means for these 4 metabolites. Although we 
do not suggest that previous studies with smaller num-
bers of subjects have underestimated normal values, 
investigators may well observe larger mean values for 
these metabolites in larger study samples. Although, 
as stated above, our sample was of diverse ethnicity, 
the few ethnic differences observed do not explain the 
higher values in some of our sample subjects.
As regards 3-HK, our means are far higher than 
literature values, which are ,1 µM.12,13,21–23 This can-
not be satisfactorily explained at present. The most 
likely  explanation  is  that  of  another  substance(s) 
co-eluting with 3-HK and the nature of such poten-
tial   co-eluant clearly requires investigation. Alterna-
tively, it is also possible that plasma [3-HK] is higher 
than previously reported in the literature. This higher 
plasma [3-HK] cannot be explained by the method 
of extraction, because low levels are observed using 
a  similar    HClO4-based  extraction  procedure.22,23 
A    puzzling  aspect  in  this  regard  is  that  plasma 
3-HK values previously reported do not reflect uri-
nary excretion levels. Thus, in three   studies report-
ing 24 h urinary excretion data of kynurenine and its 
metabolites under basal conditions (ie, before acute 
Trp loading), the first24 reported values (in µmol/24 
h) of 21.9, 78.2, 59.8, 29.7, 26.4, and 13.4 for K, 
3-HK,  3-HAA,  XA,  KA  and  AA  respectively,  or 
(assuming a 24 h-urine   volume of 2 L) 10.95, 39.1, 
29.9,  14.85,  13.2  and  6.7  µM    respectively.  In  the 
  second study,25 values of 11.65, 20.35, 13.25, 9.10 
and 4.80 µmol/24 h were reported for K, 3-HK, KA, 
XA and AA glucuronide   respectively, or 5.82, 10.17, 
6.62, 4.55 and 2.4 µM respectively. The third study11 
reported values for K, 3-HK, 3-HAA, KA, XA and AA 
of 5.8, 37.9, 44.4, 34.4, 29.7 and 8.0 µM respectively. 
From these data, it is clear that, among others, 3-HK 
and 3-HAA are excreted in urine in greater amounts 
than K, in   contrast to their much lower plasma lev-
els. The ratio of [3-HK]/[K] (µM/µM) in urine in 
these three studies therefore were 3.57, 1.75 and 6.53 
respectively. The corresponding ratio in plasma or 
serum estimated from studies in which both K and 
3-HK data have been reported (see refs12,13,20,23 and 
references cited therein) were much lower (varying 
between 0.043 and 0.19). This represents a huge dif-
ference between urinary and plasma ratios varying 
between at least 9.2-fold and at most 151.9-fold. By 
contrast, the plasma [3-HK]/[K] ratio in the present 
work (4.35) resembles more closely the above cor-
responding  ratio  in  urine. As  plasma  levels  reflect 
the steady state, and in view of the fact that kynure-
nine hydroxylase is the main enzyme of kynurenine 
metabolism and is not rate-limiting,26 it is difficult to 
reconcile the low plasma [3-HK] levels previously 
reported with the much higher urinary values. While 
we do not question the accuracy of previous estimates 
and recognise that, in all probability, our values for 
plasma 3-HK may be unjustifiably high, nevertheless 
further work is clearly required to resolve this plasma/
urine discrepancy. This is the more important given 
the recent discussion27 of the importance of accurate 
analytical methodology in scientific research.
In conclusion, we believe that the present rapid and 
simple isocratic HPLC procedure for   separation and 
quantification of tryptophan and 6 of its   kynurenine 
metabolites  will  contribute  to  the  analytical 
methodology  in  the  tryptophan  field.  In  particular, 
its speed renders this method suitable for processing 
large numbers of samples in high throughput work. 
Our preliminary studies with other Trp metabolites 
strongly suggest that this method could be developed 
further  to  include  other  kynurenines  and  indole 
metabolites and we encourage other investigators to 
contribute to this development.
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